No Image

Days Off

October 12, 2021 Auto Bot 0

I wanted to let everyone know that I’ll be taking this week off. Next blog post will be on Tuesday the 12th – which by […]

No Image

Waiting for CRISPR

October 12, 2021 Auto Bot 0

A recurring theme here has been the (very unusual) situation we have now in biopharma of several completely new therapeutic modes all coming up at […]

No Image

Aduhelm So Far

October 12, 2021 Auto Bot 0

Since the FDA approved Biogen’s aducanumab (brand name Aduhelm) as an antibody for Alzheimer’s therapy – a decision I thought was a ruinous mistake – […]

No Image

Making It Work

October 12, 2021 Auto Bot 0

Process chemistry doesn’t get its due, and it never has. For those outside the field, that’s the speciality that finds new and improved routes to […]

No Image

Rethinking Obesity

October 12, 2021 Auto Bot 0

Like many people, I have a shelf that has several of my old high school and college yearbooks on it. The faces and scenes they […]

No Image

Hiring Away

October 12, 2021 Auto Bot 0

I’ve written here several times about the vast amounts of money that have been pouring into biopharma in the last few years – both the […]

No Image

Awful Trials, With Awful Results

October 12, 2021 Auto Bot 0

It’s not news to say that the scientific signal/noise during the coronavirus pandemic has been awful. Vast amount of misinformation (and outright disinformation) circulate constantly, […]

No Image

Not Acceptable

October 12, 2021 Auto Bot 0

It’s comparatively old news by now, since the blog has been on “upgrade hiatus”. But we’ve recently seen two high-profile departures from prominent positions in […]

No Image

Introducing Nutrition on BODi

October 12, 2021 Auto Bot 0

We’re excited to announce that Beachbody’s new premium-level tier, Beachbody On Demand Interactive (BODi), is launching on October 19, 2021! In addition to live and […]